Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial

Mª AUXILIADORA GÓMEZ ESPAÑA2026-01-292026-01-29202210.1038/s41416-021-01638-w2-s2.0-85121550780https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/34377Cancer ResearchOncologyEffect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trialresearch article